Medtronic Introduces MiniMed™ Mio™ Advance Infusion Set Enabling Fewer Insertion Steps for People with Diabetes in the U.S.

What To Know

  • The MiniMed Mio Advance infusion set is the newest addition to the MiniMed™ portfolio of infusion sets and gives people using insulin pumps an optimal user experience with fewer steps1.
  • The MiniMed Mio Advance infusion set is inserted in only four steps — individuals simply peel, pinch, place, and press to insert the infusion set.

Medtronic plc today introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump customers in the United States. The MiniMed Mio Advance infusion set is the newest addition to the MiniMed™ portfolio of infusion sets and gives people using insulin pumps an optimal user experience with fewer steps1.

The MiniMed Mio Advance infusion set is inserted in only four steps — individuals simply peel, pinch, place, and press to insert the infusion set.

The user-friendly design of the MiniMed Mio Advance infusion set enables:

  • One-handed insertion and flexibility to access more insertion sites1 on the body such as the lower back or back of the arm.
  • A fully hidden needle before, during, and after insertion.
  • Consistent insertion force with the built-in insertion device (called a “serter”).
  • Fewer insertion steps.
  • Rotation of sites for better skin health and insulin absorption1.

“Early feedback on the MiniMed Mio Advance infusion set has been fantastic,” said Krista Sugerman, vice president and general manager, Customer Retention and Experience for the Diabetes Group at Medtronic. “Our goal is to continuously improve and innovate core technologies to help people with diabetes continue to experience greater freedom and better health. We are excited to now make this infusion set available to more people and make the daily management of diabetes easier for our customers.”

Feedback from Medtronic Ambassadors using the MiniMed Mio Advance infusion set has been overwhelmingly positive:

“It was very easy to remove off of her body and it was not painful.” – Carlos, father of 13-year-old Medtronic insulin pump user

”The Mio Advance is easy to insert and pain free throughout the duration, I really like not having to carry a separate inserter.” – Mark, Medtronic insulin pump user

The MiniMed Mio Advance infusion set launched in select countries outside the U.S. in 2018 with 85% of patients preferring it to previous infusion sets2. MiniMed Mio Advance is manufactured by ConvaTec’s Unomedical subsidiary and is only available from Medtronic.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy